Showing results (201-210 of 608) with videos related to
Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 17, 2021
Effectiveness and safety of dimethyl fumarate in progressive multiple sclerosisVanessa F Moreira Ferreira, Yanqing Liu, Brian C Healy, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 11, 2021
Effect of switching glatiramer acetate formulation from 20 mg daily to 40 mg three times weekly on immune function in multiple sclerosisKouichi Ito, Naoko Ito, Sudhir K Yadav, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 11, 2021
Patient and treatment characteristics and safety outcomes of patients with relapsing-remitting multiple sclerosis treated with natalizumab in Greece: Results from the multicenter, 5-year prospective observational study 'TOPICS greece'Panagiotis Karanasios, Georgios Karachalios, Rania Gourgioti, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 11, 2021
NMOSD-like and longitudinal extensive HTLV1-associated myelitis are extremes that flank an overlooked continuumMickael Bonnan, Stéphane Olindo, Aissatou Signate, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 7, 2022
Static and group-based trajectory analyses of factors associated with non-adherence in patients with multiple sclerosis newly-initiating once- or twice-daily oral disease-modifying therapyJacqueline A Nicholas, Natalie C Edwards, Roger A Edwards, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2023
Lower corticospinal excitability and greater fatigue among people with multiple sclerosis experiencing painHannah M Murphy, Christopher M Fetter, Nicholas J Snow, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 13, 2023
The effect of cladribine on immunoglobulin levels compared to B cell targeting therapies in multiple sclerosisMitchell J Lycett, Rodney A Lea, Vicki E Maltby, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 23, 2023
Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysisShay Menascu, Michal Siegel-Kirshenbaum, Sapir Dreyer-Alster, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 16, 2022
A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosisDejan Jakimovski, Katelyn S Kavak, Karen Zakalik, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 9, 2022
Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach-perspectives from the International Progressive MS AlliancePaola Zaratin, Brenda Banwell, Timothy Coetzee, et al.Pageof 61